Covid Shots For Young Kids Now Months Away After FDA Reverses Review Plan
The FDA's irregular proposal to fast-track its review of Pfizer-BioNTech's covid vaccine for kids under 5 were abruptly tabled in order to gather more data on the efficacy of a third low-dose shot. That pushes the timetable out to at least April.